🇺🇸 FDA
Patent

US 7141661

Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties

granted A61PA61P35/00

Quick answer

US patent 7141661 (Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P35/00